Isolation of mesenchymal stem cells (MSCs) from green fluorescent protein positive (GFP+) transgenic rodents: The grass is not always green(er)

Stem Cells and Development

Volumn 18, Issue 1, 2009, Pages 127-136

  Harting, Matthew T ^a   Jimenez, Fernando ^a   Cox Jr , Charles S ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZACITIDINE; GREEN FLUORESCENT PROTEIN; HISTONE DEACETYLASE INHIBITOR; PROTEIN ANTIBODY; REAGENT; TRICHOSTATIN A; ENZYME INHIBITOR;

ADIPOCYTE; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW; CELL CULTURE; CELL ISOLATION; CONTROLLED STUDY; DNA METHYLATION; DNA MODIFICATION; EPIGENETICS; FEMALE; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; IMMUNOPHENOTYPING; MALE; MESENCHYMAL STEM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RODENT; TRANSGENIC ANIMAL; ANIMAL; CELL DIFFERENTIATION; CELL SEPARATION; CYTOLOGY; DRUG EFFECTS; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY; PROCEDURES; REPORTER GENE;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; AZACITIDINE; CELL DIFFERENTIATION; CELL SEPARATION; DNA METHYLATION; ENZYME INHIBITORS; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HUMANS; MESENCHYMAL STEM CELLS; RODENTIA; MESENCHYMAL STROMAL CELLS;

RODENTIA;

EID: 60149093887     PISSN: 15473287     EISSN: None     Source Type: Journal    
DOI: 10.1089/scd.2008.0046     Document Type: Article

References (29)

1. Burns TC, XR Ortiz-Gonzalez, M Gutierrez-Perez, CD Keene, R Sharda, ZL Demorest, Y Jiang, M Nelson-Holte, M Soriano, Y Nakagawa, MR Luquin, JM Garcia-Verdugo, F Prosper, WC Low and CM Verfaillie. (2006). Thymidine analogs are transferred from prelabeled donor to host cells in the central nervous system after transplantation: a word of caution. Stem Cells 24:1121-1127.
2. Okabe M, M Ikawa, K Kominami, T Nakanishi and Y Nishimune. (1997). "Green mice" as a source of ubiquitous green cells. FEBS Lett 407:313-319.
3. Schmid JA and H Neumeier. (2005). Evolutions in science triggered by green fluorescent protein (GFP). Chembiochem 6:1149-1156.
4. Swenson ES, JG Price, T Brazelton and DS Krause. (2007). Limitations of green fluorescent protein as a cell lineage marker. Stem Cells 25:2593-2600.
5. Le Blanc K and M Pittenger. (2005). Mesenchymal stem cells: progress toward promise. Cytotherapy 7:36-45.
6. Hamada H, M Kobune, K Nakamura, Y Kawano, K Kato, O Honmou, K Houkin, T Matsunaga and Y Niitsu. (2005). Mesenchymal stem cells (MSC) as therapeutic cytoreagents for gene therapy. Cancer Sci 96:149-156.
7. Leo AJ and DA Grande. (2006). Mesenchymal stem cells in tissue engineering. Cells Tissues Organs 183:112-122.
8. Barbash IM, P Chouraqui, J Baron, MS Feinberg, S Etzion, A Tessone, L Miller, E Guetta, D Zipori, LH Kedes, RA Kloner and J Leor. (2003). Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108:863-868.
9. Mahmood A, D Lu, C Qu, A Goussev and M Chopp. (2006). Long-term recovery after bone marrow stromal cell treatment of traumatic brain injury in rats. J Neurosurg 104:272-277.
10. Dominici M, K Le Blanc, I Mueller, I Slaper-Cortenbach, F Marini, D Krause, R Deans, A Keating, D Prockop and E Horwitz. (2006). Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 8:315-317.
11. Harting MT, F Jimenez, S Pati, J Baumgartner and CS Cox. (2008). Immunophenotype characterization of rat bone-marrow derived mesenchymal stem cells. Cytotherapy. 10(3):243-253.
12. Breyer A, N Estharabadi, M Oki, F Ulloa, M Nelson-Holte, L Lien and Y Jiang. (2006). Multipotent adult progenitor cell isolation and culture procedures. Exp Hematol 34:1596-1601.
13. Schrepfer S, T Deuse, C Lange, R Katzenberg, H Reichenspurner, RC Robbins and MP Pelletier. (2007). Simplified protocol to isolate, purify, and culture expand mesenchymal stem cells. Stem Cells Dev 16:105-107.
14. http://www.nrrrc.missouri.edu/. Rat Resource and Research Center, Columbia, MO.
15. Lois C, EJ Hong, S Pease, EJ Brown and D Baltimore. (2002). Germline transmission and tissue-specific expression of transgenes delivered by lentiviral vectors. Science 295:868-872.
16. Katz RA, E Jack-Scott, A Narezkina, I Palagin, P Boimel, J Kulkosky, E Nicolas, JG Greger and AM Skalka. (2007). High-frequency epigenetic repression and silencing of retroviruses can be antagonized by histone deacetylase inhibitors and transcriptional activators, but uniform reactivation in cell clones is restricted by additional mechanisms. J Virol 81:2592-2604.
17. Snykers S, T Vanhaecke, A De Becker, P Papeleu, M Vinken, I Van Riet and V Rogiers. (2007). Chromatin remodeling agent trichostatin A: a key-factor in the hepatic differentiation of human mesenchymal stem cells derived of adult bone marrow. BMC Dev Biol 7:24.
18. Ronzoni S, M Faretta, M Ballarini, P Pelicci and S Minucci. (2005). New method to detect histone acetylation levels by flow cytometry. Cytometry A 66:52-61.
19. Yao S, T Sukonnik, T Kean, RR Bharadwaj, P Pasceri and J Ellis. (2004). Retrovirus silencing, variegation, extinction, and memory are controlled by a dynamic interplay of multiple epigenetic modifications. Mol Ther 10:27-36.
20. Ye NS, J Chen, GA Luo, RL Zhang, YF Zhao and YM Wang. (2006). Proteomic profiling of rat bone marrow mesenchymal stem cells induced by 5-azacytidine. Stem Cells Dev 15:665-676.
21. Brazelton TR and HM Blau. (2005). Optimizing techniques for tracking transplanted stem cells in vivo. Stem Cells 23:1251-1265.
22. Cherry SR, D Biniszkiewicz, L van Parijs, D Baltimore and R Jaenisch. (2000). Retroviral expression in embryonic stem cells and hematopoietic stem cells. Mol Cell Biol 20:7419-7426.
23. He J, Q Yang and LJ Chang. (2005). Dynamic DNA methylation and histone modifications contribute to lentiviral transgene silencing in murine embryonic carcinoma cells. J Virol 79:13497-13508.
24. Van Overstraeten-Schlogel N, M Delgaudine, Y Beguin and A Gothot. (2006). Limitations of the use of GFP transgenic mice in bone marrow transplantation studies. Leuk Lymphoma 47:1392-1393.
25. Li X, G Zhang, N Ngo, X Zhao, SR Kain and CC Huang. (1997). Deletions of the Aequorea victoria green fluorescent protein define the minimal domain required for fluorescence. J Biol Chem 272:28545-28549.
26. Pannell D, CS Osborne, S Yao, T Sukonnik, P Pasceri, A Karaiskakis, M Okano, E Li, HD Lipshitz and J Ellis. (2000). Retrovirus vector silencing is de novo methylase independent and marked by a repressive histone code. EMBO J 19:5884-5894.
27. Pannell D and J Ellis. (2001). Silencing of gene expression: implications for design of retrovirus vectors. Rev Med Virol 11:205-217.
28. Ellis J and S Yao. (2005). Retrovirus silencing and vector design: relevance to normal and cancer stem cells? Curr Gene Ther 5:367-373.
29. Swindle CS and CA Klug. (2002). Mechanisms that regulate silencing of gene expression from retroviral vectors. J Hematother Stem Cell Res 11:449-456.